PubMed · 1971 · 21 citations · 0 references
MedicineGynecologyPathologyCancer EpidemiologyCervical DiseaseCytopathologyCervical CancerCervical CytologyCervical DysplasiaCervical LesionsCervical PathologyCervicovaginal CytologyCervical Cancer PrevalenceCervical Carcinoma In SituCervical Epithelial DysplasiaInvasive Cervical Carcinoma
This statistical report on the prevalence and incidence rates of dys plasia carcinoma in situ and invasive carcinoma of the uterine cervix is based on a 10-year study of cytologic material. 310667 specimens from 148735 patients were examined by the Laboratory of Exfoliative Cytology at the University of Chicago between January 1 1959 and December 31 1969. More than half the patients were under age 34; the highest number were 20-24 years. Total lesions detected were: 3602 dysplasia; 849 carcinoma in situ; and 228 invasive carcinoma. Among 120716 patients with 1 or more negative readings in their first years of observation 1627 developed dysplasia 284 carcinoma in situ and 35 invasive carcinoma in later years. During the first year cervical dyspl asia was found in 1.75% of the 25-29 age group 1.70% in 20-24 and 1.60% in 30-34. Lowest rates were .29% for over age 40 and .99% for under age 15. Dysplasia rates continued to rise in all groups reaching 1.91% in 25-29 by Year 4 and 3.23% in 20-24 in Year 5. Peak rate of carcinoma in situ was found in the 35-39 year old group .69%. The 30-34 year old group had .68% the 20-24 group and the 40-44 group had .49% each. Rates for invasive carcinoma were highest in patients over age 49 .65%. However this condition was found in a 19-year-old patient. Lowest rates for cervical dysplasia were observed in patients currently not using either an IUD or oral contraceptives 1.15%. Those using and IUD had a rate of 3.12% and those using oral contraceptives 2.31%. For carcinoma in situ patients not using IUDs nor oral contraceptives had the lowest rate .35%. Those using either method had a rate of .57%. Lowest rate for invasive carcinoma was .02% in pregnant patients. Patients on oral contraceptives had .04% and those using an IUD 11%. Patients not using contraceptives had .14%. Total invasive carcinoma rate was .13%. It is believed the cytologic method is accurate in 93% of cases for dysplastic reactions in 94.7% of carcinoma in situ cases and in 94.3% of invasive squamous cancers of the cervix.